Rosiglitazone (Avandia) vs. Safer Diabetes Alternatives - A 2025 Comparison
Oct 15 2025
Paragraph IV Certifications: How Generics Challenge Patents to Lower Drug Prices
Learn how Paragraph IV certifications allow generic drugs to challenge brand-name patents under the Hatch-Waxman Act. Explore the legal process, 180-day exclusivity, and cost implications.
